Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Here at Allure Medical, we offer GLP-1 Agonist as part of our comprehensive medical weight loss programs
Significant fat loss can reduce peripheral estrogen production, which may affect symptoms in postmenopausal women not on HRT
Cuprous glutathione: With a note on the crystallography of glutathione
Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026
US$ 25.79
US$ 25.96
US$ 24.22
US$ 24.08
US$ 21.61
US$ 24.34
US$ 28.65
